110 related articles for article (PubMed ID: 15206235)
1. [Liposomal adriamycin: preparation, administration, and toxicity monitoring. Nursing aspects].
Panzolini S
Suppl Tumori; 2004; 3(4):S120. PubMed ID: 15206235
[No Abstract] [Full Text] [Related]
2. Liposomal doxorubicin.
Wilkinson K
Clin J Oncol Nurs; 2002; 6(1):59-61. PubMed ID: 11842492
[No Abstract] [Full Text] [Related]
3. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of anthracycline cardiotoxicity].
Rossetti R
Suppl Tumori; 2004; 3(4):S117-9. PubMed ID: 15206234
[No Abstract] [Full Text] [Related]
5. Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma.
Schmidinger M; Wenzel C; Locker GJ; Muehlbacher F; Steininger R; Gnant M; Crevenna R; Budinsky AC
Br J Cancer; 2001 Dec; 85(12):1850-2. PubMed ID: 11747325
[TBL] [Abstract][Full Text] [Related]
6. Safety aspects of pegylated liposomal doxorubicin in patients with cancer.
Alberts DS; Garcia DJ
Drugs; 1997; 54 Suppl 4():30-5. PubMed ID: 9361959
[TBL] [Abstract][Full Text] [Related]
7. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
[TBL] [Abstract][Full Text] [Related]
8. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
9. Non-pegylated liposomal doxorubicin in metastatic breast cancer patients: a valuable therapeutic option requiring caution.
Bernardi D; Errante D; Stefani M; Salvagno L
Breast; 2010 Dec; 19(6):549-50. PubMed ID: 20542696
[No Abstract] [Full Text] [Related]
10. Concurrent therapies that protect against doxorubicin-induced cardiomyopathy.
Simpson C; Herr H; Courville KA
Clin J Oncol Nurs; 2004 Oct; 8(5):497-501. PubMed ID: 15515283
[TBL] [Abstract][Full Text] [Related]
11. Liposomal anthracyclines.
Gabizon AA
Hematol Oncol Clin North Am; 1994 Apr; 8(2):431-50. PubMed ID: 8040147
[TBL] [Abstract][Full Text] [Related]
12. [Liposomal doxorubicin and palmoplantar erythrodysesthesia].
Tomb R; Stephan F; Halaby G
Ann Dermatol Venereol; 2003 Nov; 130(11):1057-8. PubMed ID: 14724543
[No Abstract] [Full Text] [Related]
13. Liposomal doxorubicin.
Tardi PG; Boman NL; Cullis PR
J Drug Target; 1996; 4(3):129-40. PubMed ID: 8959485
[TBL] [Abstract][Full Text] [Related]
14. Adriamycin cardiac toxicity: a different hypothesis.
Byfield JE
Cancer Treat Rep; 1977; 61(3):497-8. PubMed ID: 872149
[No Abstract] [Full Text] [Related]
15. Adriamycin-induced myocardial toxicity: new solutions for an old problem?
Outomuro D; Grana DR; Azzato F; Milei J
Int J Cardiol; 2007 Apr; 117(1):6-15. PubMed ID: 16863672
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of liposomal forms of cytostatics].
Dranov AL; Dudnichenko AS; Mezin IA; Menzeleev RF; Krasnopol'skiĭ IuM; Shvets VI
Biull Eksp Biol Med; 1996 Jan; 121(1):85-8. PubMed ID: 8680014
[No Abstract] [Full Text] [Related]
17. Liposomal doxorubicin-associated acute hypersensitivity despite appropriate preventive measures.
Chan A; Shih V; Tham Chee Kian
J Oncol Pharm Pract; 2007 Jun; 13(2):105-7. PubMed ID: 17873110
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric cancer].
Akamo Y; Mizuno I; Takeyama H; Mohri N; Ueda T; Shibata T; Yotsuyanagi T; Manabe T
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1712-4. PubMed ID: 9382513
[TBL] [Abstract][Full Text] [Related]
19. Cardiotoxicity after liposomal anthracyclines.
Young AM; Dhillon T; Bower M
Lancet Oncol; 2004 Nov; 5(11):654. PubMed ID: 15522651
[No Abstract] [Full Text] [Related]
20. A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993).
Coleman RE; Biganzoli L; Canney P; Dirix L; Mauriac L; Chollet P; Batter V; Ngalula-Kabanga E; Dittrich C; Piccart M
Eur J Cancer; 2006 May; 42(7):882-7. PubMed ID: 16520033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
